JP2022536581A5 - - Google Patents

Info

Publication number
JP2022536581A5
JP2022536581A5 JP2021561910A JP2021561910A JP2022536581A5 JP 2022536581 A5 JP2022536581 A5 JP 2022536581A5 JP 2021561910 A JP2021561910 A JP 2021561910A JP 2021561910 A JP2021561910 A JP 2021561910A JP 2022536581 A5 JP2022536581 A5 JP 2022536581A5
Authority
JP
Japan
Prior art keywords
polypeptide
amino acid
polypeptides
tmmp
terminus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021561910A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022536581A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/037919 external-priority patent/WO2020257191A1/en
Publication of JP2022536581A publication Critical patent/JP2022536581A/ja
Publication of JP2022536581A5 publication Critical patent/JP2022536581A5/ja
Pending legal-status Critical Current

Links

JP2021561910A 2019-06-19 2020-06-16 多量体ｔ細胞調節性ポリペプチド及びその使用方法 Pending JP2022536581A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962863754P 2019-06-19 2019-06-19
US62/863,754 2019-06-19
PCT/US2020/037919 WO2020257191A1 (en) 2019-06-19 2020-06-16 Multimeric t-cell modulatory polypeptides and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2022536581A JP2022536581A (ja) 2022-08-18
JP2022536581A5 true JP2022536581A5 (OSRAM) 2023-06-16

Family

ID=74040105

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021561910A Pending JP2022536581A (ja) 2019-06-19 2020-06-16 多量体ｔ細胞調節性ポリペプチド及びその使用方法

Country Status (4)

Country Link
US (1) US20220017597A1 (OSRAM)
EP (1) EP3986448A4 (OSRAM)
JP (1) JP2022536581A (OSRAM)
WO (1) WO2020257191A1 (OSRAM)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11505591B2 (en) * 2016-05-18 2022-11-22 Cue Biopharma, Inc. T-cell modulatory multimeric polypeptides and methods of use thereof
KR102760578B1 (ko) 2016-12-22 2025-02-03 큐 바이오파마, 인크. T-세포 조절 다량체 폴리펩타이드 및 이의 사용 방법
US11851471B2 (en) 2017-01-09 2023-12-26 Cue Biopharma, Inc. T-cell modulatory multimeric polypeptides and methods of use thereof
IL269000B2 (en) 2017-03-15 2024-06-01 Cue Biopharma Inc Methods for modulating an immune response
TW201920249A (zh) 2017-09-07 2019-06-01 美商信號生物製藥公司 具有結合位點之t細胞調節多聚體多肽及其使用方法
CN111886241A (zh) 2018-01-09 2020-11-03 库尔生物制药有限公司 多聚体t细胞调节多肽及其使用方法
AU2019401183A1 (en) * 2018-12-19 2021-08-12 Cue Biopharma, Inc. Multimeric T-cell modulatory polypeptides and methods of use thereof
WO2021231376A2 (en) 2020-05-12 2021-11-18 Cue Biopharma, Inc. Multimeric t-cell modulatory polypeptides and methods of use thereof
EP4211149A4 (en) 2020-09-09 2024-10-09 Cue Biopharma, Inc. MULTIMERIC POLYPEPTIDES MODULATING MHC CLASS II T CELLS FOR THE TREATMENT OF TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF
TW202233694A (zh) * 2021-02-07 2022-09-01 大陸商正大天晴藥業集團股份有限公司 雙特異性抗體
CA3212382A1 (en) * 2021-03-19 2022-09-22 Ronald D. Seidel Iii T-cell modulatory polypeptides and methods of use thereof
JP2024518680A (ja) * 2021-03-19 2024-05-02 キュー バイオファーマ， インコーポレイテッド Ｔ細胞調節ポリペプチド及びその使用方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4480800B2 (ja) * 1997-05-08 2010-06-16 オンコシリオン・インコーポレイテッド 活性化ｔ細胞および抗原パルス標識した抗原提示細胞を生成する方法
US7696306B2 (en) * 2003-07-11 2010-04-13 Board of Agents of the University of Nebraska Compositions and methods for preventing or treating cancer
ES2633894T3 (es) * 2012-08-02 2017-09-25 F. Hoffmann-La Roche Ag Procedimiento para producir moléculas monoméricas y multiméricas y usos de las mismas
PT3480213T (pt) * 2014-06-18 2020-02-04 Albert Einstein College Medicine Polipéptidos syntac e utilizações dos mesmos
WO2017023779A1 (en) * 2015-07-31 2017-02-09 Tarveda Therapeutics, Inc. Compositions and methods for immuno-oncology therapies
AU2017225787B2 (en) * 2016-03-03 2021-09-23 Cue Biopharma, Inc. T-cell modulatory multimeric polypeptides and methods of use thereof
CN109415416A (zh) * 2016-03-04 2019-03-01 纽约大学 用于诱导抗肿瘤免疫的表达肿瘤相关抗原的多表位的病毒介体
US11505591B2 (en) * 2016-05-18 2022-11-22 Cue Biopharma, Inc. T-cell modulatory multimeric polypeptides and methods of use thereof
BR112019011799B1 (pt) * 2016-12-13 2021-12-21 Delinia, Inc Proteína de fusão, proteína dimérica e composição farmacêutica
KR102760578B1 (ko) * 2016-12-22 2025-02-03 큐 바이오파마, 인크. T-세포 조절 다량체 폴리펩타이드 및 이의 사용 방법
EP3592381A1 (en) * 2017-03-09 2020-01-15 President and Fellows of Harvard College Cancer vaccine
IL269000B2 (en) * 2017-03-15 2024-06-01 Cue Biopharma Inc Methods for modulating an immune response
EP3446702A1 (en) * 2017-08-23 2019-02-27 Medizinische Hochschule Hannover Synthetic vaccine
TW201920249A (zh) * 2017-09-07 2019-06-01 美商信號生物製藥公司 具有結合位點之t細胞調節多聚體多肽及其使用方法
EA202090471A1 (ru) * 2017-09-07 2020-06-10 Кью Биофарма, Инк. Модулирующие т-клетки мультимерные полипептиды и способы их применения

Similar Documents

Publication Publication Date Title
JP2022515330A5 (OSRAM)
JP2022548472A5 (OSRAM)
IL272085B2 (en) Multimeric t-cell modulatory polypeptides and methods of use thereof
JP2021500855A5 (OSRAM)
JP2019512222A5 (OSRAM)
IL308851B1 (en) T cell modulatory multimeric polypeptides and methods of using them
JP2022534846A5 (OSRAM)
JP2023059873A5 (OSRAM)
CN110785435B (zh) 与il-12和il-18的基于il-15的融合物
JP2023527049A5 (OSRAM)
JP2017519491A5 (OSRAM)
JP2018525006A5 (OSRAM)
JP2024512470A5 (OSRAM)
JP2020533273A5 (OSRAM)
US10865243B2 (en) Chimeric antigen receptor and its use
JP2021137024A5 (OSRAM)
JP2022109953A5 (OSRAM)
JP2020514375A5 (OSRAM)
JP2022515331A5 (OSRAM)
CA2764649C (en) Multimeric polypeptides of hla-g including alpha1-alpha3 monomers and pharmaceutical uses thereof
JP2022522405A5 (OSRAM)
JP2019501647A5 (OSRAM)
JP2023526723A5 (OSRAM)
CA2318482A1 (en) Il-18 receptors
CA2407680A1 (en) Dendritic cell co-stimulator molecules